For tumor cells, this means that inhibition of PDK1 can hinder the progression of the cell cycle, leading to slowed or stagnant tumor cell proliferation, thereby preventing its excessive proliferation and exhibiting potential anti-tumor effects. The gene discussed is PDK1; the disease is neoplasm.